Join the Brain Tumor group to help and get support from people like you.
Brain Tumor News
Related terms: Brain Cancer, Brain Tumor, metastatic, Cancer, Brain, Intracranial Tumors
Why Are Brain Tumors More Deadly for Kids in Poorer Neighborhoods?
MONDAY, June 24, 2024 – U.S. children with inoperable brain tumors appear to die sooner and find it harder to get care if they live in poorer neighborhoods, a new study finds. Children from...
Epilepsy Surgery for Neuroglial Tumors Shows Good Long-Term Outcomes
MONDAY, June 17, 2024 – Patients with neuroglial tumors are ideal epilepsy surgical candidates, with good long-term outcomes observed, according to a study published online May 22 in Frontiers in ...
Your Head Aches: What Could It Mean, and What Can Be Done About It?
SUNDAY, June 9, 2024 – When there's pain, pressure and pounding in your head, you might think the worst: Is it a brain tumor? Probably not, a Penn State physician assures. Headache in and of itself ...
Ultrasound Device Delivers Meds to Better Fight Brain Tumors
THURSDAY, June 6, 2024 – One of the biggest obstacles to treating brain cancer is getting tumor-killing drugs past the blood-brain barrier that normally protects the brain from foreign invaders....
Prolonged Use of Progestogens May Raise Risk for Intracranial Meningioma
FRIDAY, March 29, 2024 – Prolonged use of medrogestone, medroxyprogesterone acetate, and promegestone is associated with an increased risk for intracranial meningioma, according to a study published...
Hormonal Meds for Birth Control, Menopause Linked to Brain Tumors
THURSDAY, March 28, 2024 – The contraceptive injection Depo-Provera and two drugs used for menopause relief could be linked to a heightened risk for brain tumors in some women, a new study warns....
New Immune-Focused Therapy, CAR T Cell Therapy, Shrinks Aggressive Brain Tumors
THURSDAY, March 14, 2024 – Delivering dual-targeted, immune-focused CAR T cancer therapy via a patient's spinal fluid quickly shrank deadly brain tumors, researchers report. CAR T therapy harnesses...
Brain Cancer Risk Increased After Moderate/Severe, Penetrating TBI
FRIDAY, Feb. 16. 2024 – Moderate/severe and penetrating traumatic brain injury (TBI) are associated with an increased risk for subsequent development of brain cancer, according to a study published...
Brain Cancer Risk Rises in Vets After Serious Head Injury
FRIDAY, Feb. 16, 2024 – People who’ve suffered a moderate to severe traumatic brain injury have a greatly increased risk of brain cancer, a new study of military service members finds. Brain cancer i...
Rock On: He Played Guitar While Getting His Brain Tumor Removed
WEDNESDAY, Jan. 10, 2024 – Professional guitarist Christian Nolen took his stage show to an operating room last month, strumming out Deftones tunes for surgeons as they worked to remove a tumor from...
FDA Approves Gleolan (aminolevulinic acid hydrochloride) as an Optical Imaging Agent in Patients with Gliomas
June 6, 2017 - The U.S. Food and Drug Administration (FDA) has approved Gleolan [aminolevulinic acid hydrochloride (ALA HCl)] as an optical imaging agent indicated in patients with gliomas (suspected...
FDA Medwatch Alert: BiCNU (carmustine for injection): FDA Alert - Counterfeit Product Discovered in Some Foreign Countries
ISSUE: FDA is informing health care professionals that a counterfeit version of the FDA approved cancer drug, BiCNU (carmustine for injection) 100 mg, has been detected in some foreign countries....
FDA Approves Afinitor Disperz - First Drug Formulated for Children with Rare Brain Tumor
The U.S. Food and Drug Administration today approved Afinitor Disperz (everolimus tablets for oral suspension), a new pediatric dosage form of the anti-cancer drug Afinitor (everolimus) used to treat...
Ask a question
To post your own question to this support group, sign in or create an account.